Rare diseases
Investigational molecules
Locations
Back to France1 164 clinical trials in Bordeaux, France across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)Study of Acalabrutinib for Patients with Chronic Lymphocytic Leukemia
FranceStudy of Zanubrutinib and Rituximab Compared to Bendamustine and Rituximab for Patients with Untreated Mantle Cell Lymphoma Ineligible for Stem Cell Transplant
FranceStudy on the Dose and Safety of Asciminib in Children with Chronic Myeloid Leukemia
FranceStudy of MK-2870 for Patients with Advanced or Metastatic Stomach Cancer, Comparing Its Effects to a Drug Combination
FranceFranceStudy on Amlitelimab for Patients Aged 12 and Older with Moderate to Severe Atopic Dermatitis Using Topical Corticosteroids and Inadequate Response to Previous Treatments
FranceStudy on the Safety and Effectiveness of AZD7789 for Patients with Advanced or Metastatic Solid Tumors, Including Non-small Cell Lung Cancer and Gastric Cancer
FranceStudy of Ibrutinib and Rituximab for Patients with Untreated Marginal Zone Lymphoma
FranceStudy of Dazostinag and Pembrolizumab for Adults with Advanced or Metastatic Solid Tumors
FranceStudy on Reducing Hormone Therapy Duration with Exemestane, Letrozole, and Anastrozole in Post-Menopausal Women with Low-Risk Hormone-Sensitive Breast Cancer
FranceStudy Comparing Zanubrutinib with Bendamustine and Rituximab for Patients with Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
FranceStudy of Paclitaxel, Carboplatin, and Durvalumab with or without Oleclumab for Patients with Untreated Advanced Triple-Negative Breast Cancer
FranceThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on psoriatic arthritis and hidradenitis suppurativa, evaluating new therapeutic combinations and treatment strategies. Studies explore the effectiveness of targeted therapies and novel approaches like fecal microbiota transplantation.
Clinical trials aim to improve patient outcomes through combination therapies and innovative treatment approaches.
Comprehensive studies investigating treatments for various cancers, including head and neck squamous cell carcinoma, endometrial cancer, and bladder cancer. Research focuses on immunotherapy combinations and targeted treatments.
Trials evaluate novel drug combinations and therapeutic approaches for better cancer treatment outcomes.
Ground-breaking research in kidney transplantation, focusing on preventing rejection and improving long-term outcomes. Studies evaluate new immunosuppressive strategies and antibody-mediated rejection treatments.
Research aims to enhance transplant success rates and patient quality of life.
Studies examining multiple sclerosis, narcolepsy, and major depressive disorder. Research investigates neuroinflammation patterns and innovative treatment approaches.
Trials focus on understanding disease mechanisms and developing targeted therapies.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
